![Brain Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/05/2026
Brain Roberts currently works at Rezolute, Inc., as Chief Medical Officer from 2022.
Dr. Roberts also formerly worked at FibroGen, Inc., as Senior Director from 2012 to 2017.
Dr. Roberts received his undergraduate degree from the University of California San Diego and doctorate degree from Georgetown University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
REZOLUTE, INC. 0,36 % | 02/03/2026 | 312.413 ( 0,36 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REZOLUTE, INC. | Director Técnico/Científico/I+D | 01/06/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| KYNTRA BIO, INC. | Director/Miembro de la Junta | 01/04/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
